paper-with-me

Papers

Causal Discovery on the Effect of Antipsychotic Drugs on Delirium Patients in the ICU using Large EHR Dataset

2022-04-28 · Riddhiman Adib, Md Osman Gani, Sheikh Iqbal Ahamed, Mohammad Adibuzzaman

Delirium occurs in about 80% cases in the Intensive Care Unit (ICU) and is associated with a longer hospital stay, increased mortality and other related issues. Delirium does not have any biomarker-based diagnosis and is commonly treated with antipsychotic drugs (APD). However, multiple studies have shown controversy over the efficacy or safety of APD in treating delirium. Since randomized controlled trials (RCT) are costly and time-expensive, we aim to approach the research question of the efficacy of APD in the treatment of delirium using retrospective cohort analysis. We plan to use the Causal inference framework to look for the underlying causal structure model, leveraging the availability of large observational data on ICU patients. To explore safety outcomes associated with APD, we aim to build a causal model for delirium in the ICU using large observational data sets connecting various covariates correlated with delirium. We utilized the MIMIC III database, an extensive electronic health records (EHR) dataset with 53,423 distinct hospital admissions. Our null hypothesis is: there is no significant difference in outcomes for delirium patients under different drug-group in the ICU. Through our exploratory, machine learning based and causal analysis, we had findings such as: mean length-of-stay and max length-of-stay is higher for patients in Haloperidol drug group, and haloperidol group has a higher rate of death in a year compared to other two-groups. Our generated causal model explicitly shows the functional relationships between different covariates. For future work, we plan to do time-varying analysis on the dataset.

📄 PDF Abstract BibTeX arXiv:2205.01057

Code (0)

등록된 구현이 없습니다.

Tasks

Causal DiscoveryCausal Inference

Similar Papers 제목 키워드 기반

Multi-objective generative AI for designing novel brain-targeting small molecules

2024-04-16 · Ayush Noori, Iñaki Arango, William E. Byrd, Nada Amin

The strict selectivity of the blood-brain barrier (BBB) represents one of the most formidable challenges to successful central nervous system (CNS) drug delivery. Computational methods to generate BBB permeable drugs in …

Drug DesignGraph Neural NetworkMolecular Docking

Effect of antipsychotics on community structure in functional brain networks

2018-05-31 · Ryan Flanagan, Lucas Lacasa, Emma K. Towlson, Sang Hoon Lee 외

Schizophrenia, a mental disorder that is characterized by abnormal social behavior and failure to distinguish one's own thoughts and ideas from reality, has been associated with structural abnormalities in the architectu…

A Polyunsaturated Fatty Acid (PUFA) Theory of Schizophrenia

2024-08-13 · Ari Rappoport

I present a theory of schizophrenia (SZ) that mechanistically explains its etiology, symptoms, pathophysiology, and treatment. SZ involves the chronic release of membrane polyunsaturated fatty acids (PUFAs) and their uti…

Causal inference in drug discovery and development

2022-09-29 · Tom Michoel, Jitao David Zhang

To discover new drugs is to seek and to prove causality. As an emerging approach leveraging human knowledge and creativity, data, and machine intelligence, causal inference holds the promise of reducing cognitive bias an…

Causal InferenceDecision MakingDrug Discovery

CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability

2024-03-12 · Gregory W. Kyro, Matthew T. Martin, Eric D. Watt, Victor S. Batista

The link between in vitro hERG ion channel inhibition and subsequent in vivo QT interval prolongation, a critical risk factor for the development of arrythmias such as Torsade de Pointes, is so well established that in v…

Drug Discovery